Danijel Sikic
Papers
2
Total Citations
13
H-Index
2
About
Danijel Sikic is a leading urologic oncologist whose research centers on optimizing surgical outcomes and patient-centered care in prostate cancer treatment. His major contributions lie in evaluating the comparative effectiveness of robot-assisted versus open radical prostatectomy, with a particular focus on patient-reported outcomes and treatment regret. Sikic’s landmark multicenter IMPROVE study, which has garnered 9 citations, revealed that patients undergoing robot-assisted surgery report significantly less regret about their treatment choice compared to those receiving open surgery—a finding that directly informs shared decision-making in clinical practice. His subsequent work, with 4 citations, demonstrates that patients treated at certified prostate cancer centers experience superior outcomes, including reduced stress urinary incontinence, highlighting the importance of specialized care. By prioritizing the patient’s perspective and systematically measuring regret and quality of life, Sikic has advanced the field beyond traditional oncologic endpoints, empowering clinicians to tailor surgical approaches that align with individual values. His research bridges the gap between technical innovation and humanistic care, making him a pivotal figure in evidence-based urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2